Company profile · Internet & IT Services
Hinge Health, Inc. (HNGE)
NYSE: HNGE · San Francisco, CA · Data from SEC filings, updated Oct 6, 2026
Overview
Hinge Health, Inc. trades on NYSE under the ticker HNGE and is classified by RoxMag in the Internet & IT Services segment (SEC industry code 7374, Services-Computer Processing & Data Preparation). Its principal executive offices are in San Francisco, CA. In its annual report for the fiscal year ended December 31, 2025, it reported revenue of $587.9 million and a net loss of $528.3 million. By public float it ranks #52 of the 126 internet & it services companies profiled on RoxMag.
Financial history
Annual figures as reported in Hinge Health, Inc.'s 10-K filings (US dollars).
- Revenue growth
- 50.6%
- vs prior year, FY2025
- Net margin
- -89.9%
- net income ÷ revenue, FY2025
- Operating margin
- -92.9%
- operating income ÷ revenue, FY2025
- R&D share of revenue
- 62.6%
- R&D ÷ revenue, FY2025
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $587.9M | $390.4M | $292.7M | — |
| Gross profit | $468.2M | $299.9M | $194.2M | — |
| Operating income | -$546.4M | -$31.9M | -$130.5M | — |
| Net income | -$528.3M | -$11.9M | -$108.1M | — |
| Research & development | $368.1M | $100.8M | $110.1M | — |
| Total assets | $744.8M | $673.3M | — | — |
| Stockholders' equity | $178.7M | -$434.6M | -$424.0M | -$318.1M |
| Cash & equivalents | $208.0M | $300.8M | $235.0M | — |
Fiscal-year labels follow the calendar year in which each fiscal year ends. Margins and growth are calculated by RoxMag from the reported figures.
Recent SEC filings
Sources & method
Company identity, address, filings, financial figures, share counts and public float come from the company's own filings with the U.S. Securities and Exchange Commission (EDGAR). Website, founding year, chief executive and employee count come from Wikidata where available; the overview excerpt is from Wikipedia. Fields without a public source are left blank. RoxMag does not estimate figures. This page is general information, not investment advice — see our disclaimer and editorial policy.